Page 197 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023 GEEDL
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
• Glycosphingolipids assessments of Gaucher disease patients from dried blood spots
samples by LC/MS−MS.
19th Annual WORLD Symposium. Orlando, US, 21-26 de febrero de 2023.
Arévalo I, López de Frutos L, Serrano Gonzalo I, Lahoz C, Mozas P, Giraldo P, Ferraz MJ,
Aerts J.
• Extensive femur location and homogeneous infiltration pattern are predictive of se-
verity of bone disease: Re-assessing MRI bone marrow involvement in Gaucher dis-
ease through machine learning.
19th Annual WORLD Symposium. Orlando, US, 21-26 de febrero de 2023.
Giraldo P, Valero-Tena E, Verdú-Díaz J, Díaz Manera J, Arévalo-Vargas I, Serrano Gonzalo
I, Köhler R, Roca-Espiau MM, Andrade-Campos M.
• Ecological study to determine the estimated prevalence of patients with acid sphin-
gomyelinase deficiency in Spain: PREVASMD study.
19th Annual WORLD Symposium. Orlando, US, 21-26 de febrero de 2023.
Villarrubia J, Morales M, Ceberio L, Vitoria I, Bellusci M, Quiñones I, Peña L, Ruiz de Val-
buena M, O’Callaghan M.
• Value contribution of olipudase alfa therapy for the treatment of non-central nervous
system manifestations of acid sphingomyelinase deficiency (ASMD) by multi-criteria
decision analysis (MCDA).
19th Annual WORLD Symposium. Orlando, US, 21-26 de febrero de 2023.
Abad MR, González-Meneses A, Gras E, Poveda JL, Trillo JL, de Vicente D, Villarubia J,
Baret M, Badia X.
• Phospholipid changes and the effect of medication in Gaucher disease and Parkin-
son’s disease.
19th Annual WORLD Symposium. Orlando, US, 21-26 de febrero de 2023.
Miltenberger Miltenyi G.
• Impact of neutrophil extracellular traps (NET) and macrophage activation in the
thrombotic events in COVID-19 patients.
European Hematology Association (EHA) Congress 2023. Frankfurt, 8-15 de junio.
Serrano-Gonzalo I, Menéndez-Jandula B, Arévalo-Vargas I, Franco-García E, Lahoz C,
Latre P, López De Frutos L, Köhler R, Giraldo P.
• Study of the development and involvement of neutrophil extracellular traps (NETs) in
vascular complications in lysosomal disorders.
197